The array of microorganisms residing at various body-sites of human, known as the human microbiome, is one of the key determinants of human health and disease. The overall goal of our microbiome and metagenomics research is systems-level characterization of metabolic interactions within microbial communities in both healthy and different disease states by high-throughput sequencing techniques and state-of-art software development. Some of the planned projects:
(a) Understanding microbial co-occurrence relationships in different body-sites
(b) Identification of oral microbiome signature for malignant transformation from leukoplakia.
(c) Microbiome associated with periodontitis as a possible early sign of diabetes mellitus.